ponasterone a has been researched along with Skin Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, M; Hozumi, Y; Kondo, S; Mine, M; Suzuki, K; Udono, MU; Watanabe, M; Yamauchi, M | 1 |
| Chen, S; Goydos, JS; Wall, BA; Wangari-Talbot, J | 1 |
2 other study(ies) available for ponasterone a and Skin Neoplasms
| Article | Year |
|---|---|
Establishment of ponasterone A-inducible the wild-type p53 protein-expressing clones from HSC-1 cells, cell growth suppression by p53 expression and the suppression mechanism.
Topics: Carcinoma; Cell Division; Cell Line, Tumor; Cellular Senescence; Ecdysterone; Feasibility Studies; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Plasmids; Skin Neoplasms; Transfection; Tumor Suppressor Protein p53 | 2009 |
Functional effects of GRM1 suppression in human melanoma cells.
Topics: Animals; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Doxycycline; Ecdysterone; Gene Expression Regulation, Neoplastic; Genetic Therapy; HEK293 Cells; Humans; Immunohistochemistry; MAP Kinase Signaling System; Melanoma; Mice; Mice, Nude; Mice, Transgenic; Mitogen-Activated Protein Kinases; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphorylation; Random Allocation; Receptors, Metabotropic Glutamate; RNA, Small Interfering; Skin Neoplasms; Xenograft Model Antitumor Assays | 2012 |